Dermtek Pharma

Dermtek Pharma is a private Canadian pharmaceutical company specializing in the development and commercialization of dermatological products. Founded in 1985 by Robert Lavoie, the company is recognized for its innovation in sun protection, notably developing the Ombrelle brand which was later sold to L'Oreal. Dermtek continues to manage a robust portfolio of therapeutic and cosmeceutical brands, including Reversa for anti-aging and Zostrix for topical pain relief. The company focuses on high-quality topical formulations to address conditions such as acne, photoaging, and chronic pain. Headquartered in Pointe-Claire, Quebec, Dermtek remains a significant player in the Canadian skincare market. Its products are widely distributed through pharmacies and recommended by dermatologists across Canada.